The Light Therapy Market is gaining momentum as healthcare providers and consumers increasingly seek non-invasive and convenient treatment options for dermatological, psychological, and ophthalmic conditions. Light therapy uses specific wavelengths of light to support the management of conditions such as psoriasis, vitiligo, eczema, acne, seasonal affective disorder, and certain sleep-related problems. The expanding applications of phototherapy are creating new opportunities for manufacturers and healthcare providers.

According to Market Research Future, the global Light Therapy Market was valued at USD 1.10 billion in 2025 and is projected to grow from USD 1.15 billion in 2026 to USD 1.74 billion by 2035, registering a CAGR of 4.72% during the forecast period 2026–2035. Clinical validation across dermatology, psychiatry, and ophthalmology is supporting continued adoption.

Technological advancements are playing an important role in market development. Traditional systems are increasingly being supplemented or replaced by LED-based devices capable of delivering targeted wavelengths with improved energy efficiency. Modern devices are also becoming more compact, portable, and suitable for home use. These characteristics are helping expand light therapy beyond hospitals and specialized clinics.

The growing prevalence of skin disorders is another important factor supporting demand. Conditions such as psoriasis, vitiligo, eczema, and acne can require long-term management, creating demand for repeated phototherapy sessions. At the same time, increasing awareness of seasonal affective disorder, sleep disturbances, and mood-related conditions is broadening the use of light-based treatment.

Homecare is emerging as an attractive end-user environment because patients increasingly prefer convenient treatment solutions. Portable light boxes, lamps, visors, and handheld systems allow patients to incorporate therapy into their daily routines. The validation of home-use phototherapy can further support decentralized treatment models.

Regionally, North America remains a leading market, accounting for 47.4% of the market according to the latest MRFR analysis. Asia-Pacific is identified as the fastest-growing region, with a projected CAGR of 5.39% through 2035.

Overall, the Light Therapy Market is positioned for sustained expansion as technological innovation, home-based treatment, increasing disease awareness, and broader clinical applications continue to influence the healthcare landscape.